Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin Extended Release in Postherpetic Neuralgia
NCT00636636Phase 3Completed
- Sponsor
- Assertio
- Start
- Mar 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of gabapentin in postherpetic neuralgia (PHN), sponsored by Assertio. Started Mar 2008; status: completed.
02
Drugs
gabapentin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00636636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00636636.